A detailed history of True Vision Mn LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, True Vision Mn LLC holds 1,044 shares of VRTX stock, worth $524,557. This represents 0.32% of its overall portfolio holdings.

Number of Shares
1,044
Previous 1,042 0.19%
Holding current value
$524,557
Previous $414 Million 18.15%
% of portfolio
0.32%
Previous 0.29%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
$392.81 - $485.53 $785 - $971
2 Added 0.19%
1,044 $489 Million
Q1 2024

Apr 30, 2024

BUY
$407.69 - $446.08 $44,845 - $49,068
110 Added 11.8%
1,042 $414 Million
Q4 2023

Mar 05, 2024

BUY
$343.0 - $410.68 $319,676 - $382,753
932 New
932 $379 Million

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $129B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track True Vision Mn LLC Portfolio

Follow True Vision Mn LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of True Vision Mn LLC, based on Form 13F filings with the SEC.

News

Stay updated on True Vision Mn LLC with notifications on news.